Nanomedicines: addressing the scientific and regulatory gap.

  title={Nanomedicines: addressing the scientific and regulatory gap.},
  author={Sally S. Tinkle and Scott E. McNeil and Stefan F M{\"u}hlebach and Raj Bawa and Gerrit Borchard and Yechezkel Chezy Barenholz and Lawrence Tamarkin and Neil Desai},
  journal={Annals of the New York Academy of Sciences},
Nanomedicine is the application of nanotechnology to the discipline of medicine: the use of nanoscale materials for the diagnosis, monitoring, control, prevention, and treatment of disease. Nanomedicine holds tremendous promise to revolutionize medicine across disciplines and specialties, but this promise has yet to be fully realized. Beyond the typical complications associated with drug development, the fundamentally different and novel physical and chemical properties of some nanomaterials… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
30 Extracted Citations
22 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 30 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 22 references

FDA and nanotech : Baby steps lead to regulatory uncertainty

  • R. Bawa
  • American Bar Association SciTech Lawyer
  • 2013

Gela - tion of liposome interior . A novel method for drug encapsulation

  • A. Steiner A. V. Andriyanov
  • FEBS Lett .
  • 2012

Draft Guidance on Paclitaxel , 2012

  • R. Bawa
  • 2009

Similar Papers

Loading similar papers…